Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems …

Summation Copper-64 (T1/2= 12.7 hours; β+, 0.653 MeV [17.8%]; β−, 0.579 MeV [38.4%])
has decay characteristics that allow for positron emission tomography (PET) imaging and …

Molecular imaging is an emerging technology that allows the visualization of interactions
between molecular probes and biological targets. Molecules that either direct or are subject …

Copper is one of the most interesting elements for various biomedical applications. Copper
compounds show vast array of biological actions, including anti-inflammatory, anti …

Radioimmunoimaging and therapy has been an area of interest for several decades. Steady
progress has been made toward clinical translation of radiolabeled monoclonal antibodies …

Metallic radionuclides are the mainstay of both diagnostic and therapeutic
radiopharmaceuticals. Therapeutic nuclear medicine is less advanced but has tremendous …

CXCR4 is a chemokine receptor which has been shown to be exploited by various tumors
for increased survival, invasion, and homing to target organs. We developed a one step …

A first-in-human clinical trial with Positron Emission Tomography (PET) imaging of the
urokinase-type plasminogen activator receptor (uPAR) in patients with breast, prostate and …

Affibody molecules are small and robust non-immunoglobulin affinity ligands capable of
binding to a wide range of protein targets. They are selected from combinatorial libraries …

Ribonucleic acid (RNA) aptamers with high affinity and specificity for cancer-specific cell-
surface antigens are promising reagents for targeted molecular imaging of cancer using …